CYCN logo

CYCN
Cyclerion Therapeutics Inc

8,086
Mkt Cap
$13.08M
Volume
6,941.00
52W High
$8.48
52W Low
$1.03
PE Ratio
-2.57
CYCN Fundamentals
Price
$3.02
Prev Close
$2.98
Open
$2.94
50D MA
$1.94
Beta
0.30
Avg. Volume
38,806.52
EPS (Annual)
-$1.11
P/B
1.27
Rev/Employee
$2.07M
$0.7999
Loading...
Loading...
News
all
press releases
Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders?
Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders? Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 9, 2026 Insiders may stand to...
PR Newswire·11d ago
News Placeholder
More News
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWAN
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWAN $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--CYCN, CECO, THR, and CWAN...
PR Newswire·12d ago
News Placeholder
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of...
PR Newswire·18d ago
News Placeholder
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) and Korsana Biosciences, Inc. Upon closing of the proposed transaction...
Business Wire·18d ago
News Placeholder
Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today
GSAT, XOM, CYCN, LLY, INTC were among the stocks seen trending on Wednesday, April 1, 2026.read more...
Benzinga·18d ago
News Placeholder
Shareholder Alert: Ademi LLP investigates whether Cyclerion Therapeutics Inc. is obtaining a Fair Price for Public Shareholders
Shareholder Alert: Ademi LLP investigates whether Cyclerion Therapeutics Inc. is obtaining a Fair Price for Public Shareholders Shareholder Alert: Ademi LLP investigates whether Cyclerion...
PR Newswire·19d ago
News Placeholder
Promising Medical Stocks To Consider - April 1st
Eli Lilly and Company, Cyclerion Therapeutics, Apellis Pharmaceuticals, UnitedHealth Group, Novo Nordisk A/S, Boston Scientific, and Johnson & Johnson are the seven Medical stocks to watch today...
MarketBeat·19d ago
News Placeholder
Best Pharmaceutical Stocks To Follow Now - April 1st
Eli Lilly and Company, Cyclerion Therapeutics, Apellis Pharmaceuticals, Novo Nordisk A/S, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat·19d ago
News Placeholder
Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing
Cyclerion Therapeutics shares are trading sharply higher Wednesday morning after it announced a merger agreement with Korsana Biosciences.read more...
Benzinga·19d ago
News Placeholder
Biotech Reinvention Meets AI’s Buildout Boom
A powerful mix of capital formation, strategic mergers, and infrastructure-scale contracts is reshaping the small- and mid-cap landscape, as companies tied to AI, biotech innovation, and digital infrastructure race to secure relevance, and runway, in an increasingly competitive market. $TGNT, $CYCN, $TH, $SHAZ
24-7 Market News·19d ago
<
1
2
...
>

Latest CYCN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.